Pacer Advisors, Inc. Adverum Biotechnologies, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$3.36 - $10.56 $19,138 - $60,149	-5,696 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$9.26 - $14.36 $3,241 - $5,026	350 Added 6.55%	5,696 $56,000
Q4 2020 Jan 20, 2021	BUY	$9.84 - $14.26 $15,124 - $21,917	1,537 Added 40.35%	5,346 $58,000
Q3 2020 Oct 19, 2020	BUY	$10.3 - $21.64 $39,232 - $82,426	3,809 New	3,809 $39,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.